Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems? (Q58639607)

From Wikidata
Jump to navigation Jump to search
article
  • Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems?
edit
Language Label Description Also known as
English
Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems?
article
  • Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems?

Statements

Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems? (English)
0 references
Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems? (English)
0 references
0 references
Adam La Caze
0 references
2005
0 references
23
0 references
5
0 references
445-447
0 references
445-7
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit